Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M F, Botteman"'
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 12(6)
Not much is generally known regarding the burden imposed by bladder cancer upon patient health-related quality of life (HRQL). The role of HRQL in affecting patient preferences and utility assessment and, ultimately, the selection of therapeutic regi
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 11(4)
This paper is the first of its kind to study the impact of Fabry disease (FD) in affected males, and shows that FD is associated with a significant decline in several domains. Using the medical outcomes study (MOS) SF-36 and a FD-specific questionnai
Publikováno v:
The American journal of managed care. 5(8)
To compare, from a managed care perspective, the 3-year costs of 3 first-line monotherapy strategies in type 2 diabetes patients: glipizide gastrointestinal therapeutic system (GITS), metformin, and acarbose.A Markov model, with a Monte Carlo simulat
Autor:
S. Kaura, M. F. Botteman
Publikováno v:
Journal of Clinical Oncology. 27:5106-5106
5106 Background: Zoledronic acid (ZOL) significantly reduces the risk of new skeletal-related events (SREs) in patients (pts) with bone metastases from RCC. This study assessed and compared the cost-effectiveness of ZOL in pts with RCC from French, G
Publikováno v:
Rheumatology; Jul2007, Vol. 46 Issue 8, p1320-1320, 1p